Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China
Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China
复制标题
DOI：
10.1186/s12885-023-10568-0
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
杨谨
中科院分区：
文献类型：
--
作者：
杨姣;赵兵;令晓玲;李东辉;赵久达;吕勇刚;王光玺;刘新兰;李南林;杨谨
